| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/22/2011 | WO2011046972A3 Compositions and methods for suppressing primer interactions |
| 09/22/2011 | WO2011046597A3 Biomarkers for the detection of breast cancer |
| 09/22/2011 | WO2011041725A3 Schizophrenia treatment response biomarkers |
| 09/22/2011 | US20110231955 EFFICIENT GENE SILENCING IN PLANTS USING SHORT dsRNA SEQUENCES |
| 09/22/2011 | US20110231951 Clubroot resistance brassica oleracea plants |
| 09/22/2011 | US20110231942 Tiki1 and tiki2, wnt inhibitors |
| 09/22/2011 | US20110230811 Patterned gradient wound dressing and methods of using same to promote wound healing |
| 09/22/2011 | US20110230571 Diagnostic and therapeutic protocols |
| 09/22/2011 | US20110230547 Potential Prognostic Markers and Therapeutic Targets for Neurological Disorders |
| 09/22/2011 | US20110230545 Eml4-alk fusion gene |
| 09/22/2011 | US20110230544 Modulation of c-reactive protein expression |
| 09/22/2011 | US20110230540 Manassatin compounds and methods of making and using the same |
| 09/22/2011 | US20110230527 Caspase inhibitors and uses thereof |
| 09/22/2011 | US20110230506 Predictive marker for egfr inhibitor treatment |
| 09/22/2011 | US20110230469 Method to Determine the Risk for Side Effects of an SSRI Treatment in a Person |
| 09/22/2011 | US20110230451 Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection |
| 09/22/2011 | US20110230442 Na channels, disease, and related assays and compositions |
| 09/22/2011 | US20110230372 Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and outcome prediction in pediatric b-precursor acute lymphoblastic leukemia |
| 09/22/2011 | US20110230370 Discovery And Applications Of The Proteolytic Function of N-Terminal Acetylation Of Cellular Proteins |
| 09/22/2011 | US20110230369 Method for screening compounds for their ability to increase rigidity of red blood cells infected by a protozoan parasite of the genus plasmodium, method for filtering red blood cells, and application thereof |
| 09/22/2011 | US20110230366 Genetic Variants Useful for Risk Assessment of Thyroid Cancer |
| 09/22/2011 | US20110230365 Mutations Associated With Cystic Fibrosis |
| 09/22/2011 | US20110230363 Methods, kits, and compositions useful in selecting an antibiotic to treat mrsa |
| 09/22/2011 | US20110230361 Prostate cancer biomarkers to predict recurrence and metastatic potential |
| 09/22/2011 | US20110230360 Methods for stratifying and annotating cancer drug treament options |
| 09/22/2011 | US20110230358 Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing |
| 09/22/2011 | US20110230357 Method for determining the primary site of cup |
| 09/22/2011 | US20110229929 Arsenical Fluorescent Agents and Assays |
| 09/22/2011 | US20110229928 Device and method for microwave assisted cryo-sample processing |
| 09/22/2011 | US20110229927 Sample port of a cell culture system |
| 09/22/2011 | US20110229926 Storing method of measuring apparatus of airborne floating bacteria |
| 09/22/2011 | US20110229925 Assays for performance of organisms in phenotrons |
| 09/22/2011 | US20110229924 Fluorescent ion indicators and their applications |
| 09/22/2011 | US20110229923 Crystal of a cytochrome-ligand complex and methods of use |
| 09/22/2011 | US20110229922 Screening assays for the identification of bace2 inhibitors |
| 09/22/2011 | US20110229921 METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
| 09/22/2011 | US20110229920 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 09/22/2011 | US20110229919 Combination of spla2 activity and oxpl/apob cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event. |
| 09/22/2011 | US20110229918 Method of Quantifying Transient Interactions Between Proteins |
| 09/22/2011 | US20110229917 Multiplex liquid tissue™ method for increased proteomic coverage from histopathologically processed biological samples, tissues and cells |
| 09/22/2011 | US20110229916 Nanofibers with high enzyme loading for highly sensitive biosensors |
| 09/22/2011 | US20110229911 Azurophilic granule proteases as markers in cardiological diseases |
| 09/22/2011 | US20110229910 Fluorescent Substrates for Neurotransmitter Transporters |
| 09/22/2011 | US20110229906 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 09/22/2011 | US20110229905 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases rlated to beclin-1 |
| 09/22/2011 | US20110229904 Recombinant construct for detection of halogenated aromatic hydrocarbons |
| 09/22/2011 | US20110229903 Determination of immunoglobulin encoding nucleic acid |
| 09/22/2011 | US20110229902 Method for determining the resistance status of fungi and yeasts, in particular of aspergillus fumigatus |
| 09/22/2011 | US20110229901 Methods for identifying the habitats of insects |
| 09/22/2011 | US20110229900 Method for detecting microorganisms of kingella genus |
| 09/22/2011 | US20110229899 DETECTION OF MUTATIONS IN A GENE ENCODING IkB KINASE-COMPLEX-ASSOCIATED PROTEIN TO DIAGNOSE FAMILIAL DYSAUTONOMIA |
| 09/22/2011 | US20110229898 DNA analyzer |
| 09/22/2011 | US20110229897 Optical approach for microfluidic DNA electrophoresis detection |
| 09/22/2011 | US20110229896 DNA Diagnostic Screening for Turner Syndrome and Sex Chromosome Disorders |
| 09/22/2011 | US20110229895 Method for diagnosing polycystic kidney disease |
| 09/22/2011 | US20110229894 Methods for detecting an increased susceptibility to cancer |
| 09/22/2011 | US20110229893 METHOD OF MEASURING CYTOKERATIN 19 mRNA |
| 09/22/2011 | US20110229892 Method for predicting a patient's responsiveness to anti-folate therapy |
| 09/22/2011 | US20110229891 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 09/22/2011 | US20110229890 Egfr mutations |
| 09/22/2011 | US20110229889 DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Msx1/2 |
| 09/22/2011 | US20110229888 Compositions and Methods for the Detection of Genomic Features |
| 09/22/2011 | US20110229887 Detection of nucleic acid amplification products in the presence of an internal control sequence on an immunochromatographic strip |
| 09/22/2011 | US20110229886 Methods for detecting aneuploidy using microparticle multiplex detection |
| 09/22/2011 | US20110229885 Methods and Compositions for Determining Predisposition to Inflammation-Mediated Cardiovascular Disease |
| 09/22/2011 | US20110229884 Method of genome-wide nucleic acid fingerprinting of functional regions |
| 09/22/2011 | US20110229883 Biochemical Markers for Disease States and Genes for Identification of Biochemical Defects |
| 09/22/2011 | US20110229882 Diagnosing and monitoring response to treatment of solid organ tissue disease |
| 09/22/2011 | US20110229881 Dna-containing ink composition |
| 09/22/2011 | US20110229880 Gene silencing |
| 09/22/2011 | US20110229879 Methods and compositions for nuclear staining |
| 09/22/2011 | US20110229878 Human consensus sodium-iodide symporter repressor (nis-repressor) binding site |
| 09/22/2011 | US20110229877 Enzyme-pore constructs |
| 09/22/2011 | US20110229876 Biomarkers for the detection of head and neck tumors |
| 09/22/2011 | US20110229875 Method of measuring human cyp3a inducibility |
| 09/22/2011 | US20110229874 Compositions and methods useful for hcv infection |
| 09/22/2011 | US20110229870 Disintegration of cellular components in body fluids |
| 09/22/2011 | US20110229552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN |
| 09/22/2011 | US20110229531 Anti-protozoa compounds |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229498 Compositions and methods for modulating an immune response |
| 09/22/2011 | US20110229496 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | US20110229485 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 09/22/2011 | US20110229483 Tumor angiogenesis associated genes and a method for their identification |
| 09/22/2011 | US20110229482 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood by preventing viral entry into a cell |
| 09/22/2011 | US20110229480 Pta072 protein |
| 09/22/2011 | US20110229479 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| 09/22/2011 | US20110229471 Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| 09/22/2011 | US20110229470 Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis |
| 09/22/2011 | US20110229448 method for identifying antigen-specific regulatory t cells |
| 09/22/2011 | US20110229441 Method and Medium for Neural Differentiation of Pluripotent Cells |
| 09/22/2011 | US20110229440 Differentiation of Human Embryonic and Induced Pluripotent Stem Cells |
| 09/22/2011 | US20110229431 Methods useful in studying or modulating skin or hair pigmentation, plant extracts for use in compositions and cosmetic care method |
| 09/22/2011 | US20110229423 Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof |
| 09/22/2011 | US20110229411 Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment |
| 09/22/2011 | US20110229408 Sodium-iodide symporter gene repressor binding site |
| 09/22/2011 | US20110226946 Determination of testosterone by mass spectrometry |
| 09/22/2011 | CA2793660A1 Methods, kits and compositions for detection of mrsa |
| 09/22/2011 | CA2793648A1 System for purifying certain cell populations in blood or bone marrow by depleting others |